...NEW HAVEN Conn. March 3 2011 /- The launch of a new n...Turner syndrome which affects females is a chromosome problem in whi... The average age of diagnosis of Turner syndrome is about 11 years of ...XCAT-TS is a novel non-karyotype genetic test for the identification o...

NEW HAVEN, Conn., March 3, 2011 /PRNewswire/ -- The launch of a new, non-invasive test for the identification of Turner syndrome (TS) was announced today by JS Genetics. The test, XCAT-TS, is a simple cheek swab that identifies girls with Turner syndrome. Until now, Turner syndrome could only be diagnosed with a Karyotype, an invasive test that requires blood from the patient. The results of the XCAT-TS validation study were published in the February 2011 issue of Journal of Clinical Endocrinology & Metabolism.

Turner syndrome, which affects females, is a chromosome problem in which all or part of one of the two X chromosomes is missing. Girls with Turner syndrome are short and can have other medical problems such as heart abnormalities, ovarian failure, delayed menstruation, mild hearing loss, non-verbal learning disability and others.

"The average age of diagnosis of Turner syndrome is about 11 years of age, which is unfortunate because early detection and treatment of TS leads to better outcomes," stated Dr. Scott Rivkees of Yale University, a pediatric endocrinologist and co-founder of JS Genetics. "Hopefully, this new, non-invasive test will lead to earlier recognition, earlier medical interventions, and improved outcomes for these girls."

XCAT-TS is a novel non-karyotype genetic test for the identification of Turner syndrome. The test's quantitative genotyping using proprietary markers spanning the X chromosome to detect loss of chromosome material allows for accurate identification of TS with clinically meaningful sensitivity and specificity in both Classic and Mosaic forms of Turner syndrome. In addition, the XCAT-TS test can detect Y chromosome material, which if present, is associated with a higher risk of ovarian tumors in TS patients.

For more information about JS Genetics, XCAT-TS and for physicians who would like to obtain a kit at no charge, visit www.jsgenetics.com.

About JS Genetics

JS Genetics Inc., a private company, develops and markets proprietary, high value DNA diagnostic tests for medical conditions in newborns, children, and adolescents. In the past 4 years, JS Genetics has been awarded 4 Phase I and 3 Phase II Small Business Innovation Research (SBIR) grants from the National Institutes of Health. The company's strategy is to develop tests using cheek swabs for sample collection on a PCR based testing platform to bring to market accurate, convenient and scalable DNA diagnostics.

(Date:12/8/2016)... 8, 2016 Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...

(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...

(Date:12/8/2016)... Dec. 8, 2016 Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...

(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...

(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...

(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...

(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...